These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1279 related items for PubMed ID: 29971354

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The patient-reported disease burden in adults with atopic dermatitis: a cross-sectional study in Europe and Canada.
    de Bruin-Weller M, Gadkari A, Auziere S, Simpson EL, Puig L, Barbarot S, Girolomoni G, Papp K, Pink AE, Saba G, Werfel T, Eckert L.
    J Eur Acad Dermatol Venereol; 2020 May; 34(5):1026-1036. PubMed ID: 31587373
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Validation of five patient-reported outcomes for atopic dermatitis severity in adults.
    Silverberg JI, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Ong PY, Fuxench ZC, Simpson EL.
    Br J Dermatol; 2020 Jan; 182(1):104-111. PubMed ID: 30972740
    [Abstract] [Full Text] [Related]

  • 7. Extent and consequences of inadequate disease control among adults with a history of moderate to severe atopic dermatitis.
    Wei W, Anderson P, Gadkari A, Blackburn S, Moon R, Piercy J, Shinde S, Gomez J, Ghorayeb E.
    J Dermatol; 2018 Feb; 45(2):150-157. PubMed ID: 29131384
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults.
    Simpson EL, Bieber T, Eckert L, Wu R, Ardeleanu M, Graham NM, Pirozzi G, Mastey V.
    J Am Acad Dermatol; 2016 Mar; 74(3):491-8. PubMed ID: 26777100
    [Abstract] [Full Text] [Related]

  • 12. Content and construct validity, predictors, and distribution of self-reported atopic dermatitis severity in US adults.
    Silverberg JI, Chiesa Fuxench ZC, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Simpson EL, Ong PY.
    Ann Allergy Asthma Immunol; 2018 Dec; 121(6):729-734.e4. PubMed ID: 30092267
    [Abstract] [Full Text] [Related]

  • 13. Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD).
    Simpson EL, Gadkari A, Worm M, Soong W, Blauvelt A, Eckert L, Wu R, Ardeleanu M, Graham NMH, Pirozzi G, Sutherland ER, Mastey V.
    J Am Acad Dermatol; 2016 Sep; 75(3):506-515. PubMed ID: 27268421
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Severity strata for POEM, PO-SCORAD, and DLQI in US adults with atopic dermatitis.
    Silverberg JI, Gelfand JM, Margolis DJ, Fonacier L, Boguniewicz M, Schwartz LB, Simpson E, Grayson MH, Ong PY, Fuxench ZCC.
    Ann Allergy Asthma Immunol; 2018 Oct; 121(4):464-468.e3. PubMed ID: 30003968
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Validation of four single-item patient-reported assessments of sleep in adult atopic dermatitis patients.
    Lei D, Yousaf M, Janmohamed SR, Vakharia PP, Chopra R, Chavda R, Gabriel S, Sacotte R, Patel KR, Singam V, Immaneni S, Kantor R, Hsu DY, Silverberg JI.
    Ann Allergy Asthma Immunol; 2020 Mar; 124(3):261-266. PubMed ID: 31830585
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 64.